Literature DB >> 9112963

Salla disease--rare or underdiagnosed?

R O Robinson1, A H Fensom, B D Lake.   

Abstract

Salla disease is described in two English children. Eighty-seven of the 89 cases so far reported come from Finland. It may be genuinely rare outside Finland or possibly underdiagnosed. Although a lysosomal disorder, it lacks many of their more characteristic features. Deterioration, for example, in the paediatric age range is rare. The clinical features are, however, consistent and specific. Definitive diagnosis is achieved by demonstrating increased amounts of free sialic acid in cultured skin fibroblasts. If the colorimetric method in widespread use is employed for this, a false negative result may be obtained. High-pressure liquid chromatography is sufficiently sensitive. It is possible therefore that Salla disease is under-reported, both from lack of clinical awareness and from lack of appropriate laboratory confirmation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9112963     DOI: 10.1111/j.1469-8749.1997.tb07403.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  4 in total

1.  Cerebellar white matter involvement in Salla disease.

Authors:  Roberta Biancheri; A Rossi; M G Mancini; C Minetti
Journal:  Neuroradiology       Date:  2004-06-04       Impact factor: 2.804

2.  The spectrum of SLC17A5-gene mutations resulting in free sialic acid-storage diseases indicates some genotype-phenotype correlation.

Authors:  N Aula; P Salomäki; R Timonen; F Verheijen; G Mancini; J E Månsson; P Aula; L Peltonen
Journal:  Am J Hum Genet       Date:  2000-08-17       Impact factor: 11.025

3.  A case of Salla disease with involvement of the cerebellar white matter.

Authors:  T Linnankivi; T Lönnqvist; T Autti
Journal:  Neuroradiology       Date:  2003-01-16       Impact factor: 2.804

4.  Homozygosity for the p.K136E mutation in the SLC17A5 gene as cause of an Italian severe Salla disease.

Authors:  R Biancheri; A Rossi; H A Verbeek; R Schot; F Corsolini; S Assereto; G M S Mancini; F W Verheijen; C Minetti; M Filocamo
Journal:  Neurogenetics       Date:  2005-09-17       Impact factor: 2.660

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.